Cleared Traditional

K162977 - ADVIA 2120i

K162977 is the FDA 510(k) clearance for ADVIA 2120i by Siemens Healthcare Diagnostics. It is a Class 2 Hematology device (product code GKZ) cleared through the Traditional 510(k) pathway after a 289-day FDA review.

K162977 · Siemens Healthcare Diagnostics · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2017
Decision
289d
Days
Class 2
Risk

K162977 is an FDA 510(k) clearance for the ADVIA 2120i, ADVIA 2120. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Siemens Healthcare Diagnostics (Tarrytown, US). The FDA issued a Cleared decision on August 11, 2017 after a review of 289 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Healthcare Diagnostics devices

Submission Details

510(k) Number K162977 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 26, 2016
Decision Date August 11, 2017
Days to Decision 289 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 113d · This submission: 289d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K162977.
HemoScreen Hematology Analyzer
K180020 · Pixcell Medical Technologies, Ltd. · Oct 2018
cobas m 511 integrated hematology analyzer
K171655 · Roche Diagnostics Hematology, Inc. · Mar 2018
XW-100 Automated Hematology Analyzer for CLIA Waived Use
K172604 · Sysmex America, Inc. · Nov 2017
Sysmex XN-L Automated Hematology Analyzer
K160538 · Sysmex America, Inc. · Dec 2016
UniCel DxH SlideMaker Stainer Coulter Cellular Analysis System
K162414 · Beckman Coulter, Inc. · Nov 2016
XW-100 Automated Hematology Analyzer, XW QC CHECK
K143577 · Sysmex America, Inc. · Oct 2015